Discovery and SAR Studies of Orally Active Somatostatin Receptor Subtype-2 (SSTR2) Agonists for the Treatment of Acromegaly.
Ishida A, Tajima Y, Okabe Y, Matsushita T, Sekiguchi T, Imaide S, Nomura Y, Tanaka M, Nojima S, Yoshida A, Iyoda Y, Aoki S, Nishio T, Komagata T, Iwaki M, Shono T, Naganawa A, Imagawa A.
Ishida A, et al. Among authors: komagata t.
ACS Chem Neurosci. 2020 May 20;11(10):1482-1494. doi: 10.1021/acschemneuro.0c00124. Epub 2020 May 1.
ACS Chem Neurosci. 2020.
PMID: 32315148